(NP (NP A/DT concatenated/JJ form/NN) (PP of/IN (NP Epstein-Barr/JJ viral/JJ DNA/NN)) (PP in/IN (NP (NP lymphoblastoid/JJ cell/NN lines/NNS) (VP induced/VBN (NP */-NONE-) (PP by/IN (NP-LGS (NP transfection/NN) (PP with/IN (NP BZLF1/NN))))))) ./.)
(S (NP-SBJ-15 (NP The/DT replicative/JJ form/NN) (PP of/IN (NP (NP (NP Epstein-Barr/JJ virus/NN) (PRN -LRB-/-LRB- (NP EBV/NN) -RRB-/-RRB-)) DNA/NN))) (VP was/VBD (VP studied/VBN (NP *-15/-NONE-) (S (NP-SBJ */-NONE-) (VP using/VBG (NP (NP (NP two/CD lymphoblastoid/JJ cell/NN lines/NNS) ,/, (NP-COOD (NP X50-7/NN) and/CC (NP 6F11/NN)) ,/,) (SBAR (WHNP-16 which/WDT) (S (NP-SBJ-17 *T*-16/-NONE-) (VP are/VBP (VP (ADVP latently/RB) infected/VBN (NP *-17/-NONE-) (PP by/IN (NP-LGS Epstein-Barr/JJ virus/NN))))))))))) ./.)
(S (NP-SBJ-18 (NP The/DT lytic/JJ cycle/NN) (PP of/IN (NP EBV/NN infection/NN))) (VP was/VBD (VP induced/VBN (NP *-18/-NONE-) (PP by/IN (NP-LGS (NP transfection/NN) (PP of/IN (NP the/DT cells/NNS)) (PP with/IN (NP (NP the/DT BRLF1\/BZLF1/NN coding/NN region/NN) (PP of/IN (NP the/DT P3HR-1/NN defective/JJ genome/NN)))))))) ./.)
(S (NP-SBJ-19 We/PRP) (VP combined/VBD (NP two/CD techniques/NNS) (S (NP-SBJ *-19/-NONE-) (VP to/TO (VP identify/VB (NP (NP the/DT productive/JJ replicative/JJ form/NN) (PP of/IN (NP Epstein-Barr/JJ viral/JJ DNA/NN)) (PP in/IN (NP the/DT (ADJP lytic/JJ cycle-induced/JJ) cells/NNS))))))) ./.)
(S (NP-SBJ (NP Restriction/NN enzyme/NN analysis/NN) (VP followed/VBN (NP */-NONE-) (PP by/IN (NP-LGS Southern/NN blot/NN hybridization/NN)))) (VP identified/VBD (NP (NP a/DT significant/JJ increase/NN) (PP in/IN (NP (NP the/DT fused/VBN fragment/NN) (VP encompassing/VBG (NP (NP both/DT ends/NNS) (PP of/IN (NP EBV/NN DNA/NN)))))))) ./.)
(S (NP-SBJ This/DT) (VP indicates/VBZ (NP (NP an/DT increase/NN) (PP in/IN (NP-COOD either/CC (NP episomal/JJ DNA/NN) or/CC (NP concatameric/JJ linear/JJ DNA/NN))))) ./.)
(S (NP-SBJ (NP Southern/NN blot/NN analysis/NN) (PP of/IN (NP (ADJP in/FW situ/FW) lysing/VBG gels/NNS))) (VP revealed/VBD (SBAR that/IN (S (NP-SBJ-64 (NP the/DT cellular/JJ content/NN) (PP of/IN (NP linear/JJ EBV/NN DNA/NN))) (VP was/VBD (VP (ADVP also/RB) increased/VBN (NP *-64/-NONE-) (ADVP significantly/RB) (PP-TMP after/IN (NP (NP the/DT initiation/NN) (PP of/IN (NP the/DT viral/JJ lytic/JJ cycle/NN)))) ,/, (SBAR while/IN (S (NP-SBJ (NP the/DT amount/NN) (PP of/IN (NP circular/JJ DNA/NN))) (VP remained/VBD (ADJP-PRD approximately/RB constant/JJ))))))))) ./.)
(S (NP-SBJ We/PRP) (VP propose/VBP (PP from/IN (NP these/DT results/NNS)) (SBAR-COOD (SBAR that/IN (S (NP-SBJ (NP the/DT source/NN) (PP of/IN (NP (NP the/DT fused/VBN fragment/NN) (VP encompassing/VBG (NP (NP both/DT ends/NNS) (PP of/IN (NP EBV/NN DNA/NN))))))) (VP is/VBZ (NP-PRD a/DT concatenated/VBN linear/JJ EBV/NN DNA/NN molecule/NN)))) ,/, and/CC (SBAR that/IN (S (NP-SBJ such/PDT a/DT concatenated/VBN molecule/NN) (ADVP most/RBS likely/RB) (VP represents/VBZ (NP (NP a/DT replicative/JJ form/NN) (PP of/IN (NP (NP EBV/NN DNA/NN) (PP in/IN (NP (ADJP productively/RB infected/JJ) cells/NNS)))))))))) ./.)
